Bcl6 Suppresses Cardiac Fibroblast Activation and Function via Directly Binding to Smad4

Abstract

Bcl6, a critical pro-oncogene of human B-cell lymphomas, can promote tumor progress. Previous studies have found that Bcl6 participates in hypoxia injury in cardiomyocytes. However, the effect of Bcl6 on cardiac fibroblasts is still unclear. The aim of this study was to elucidate the functional role of Bcl6 in cardiac fibroblast activation and function. The neonatal rat cardiac fibroblasts were isolated and cultured. First, transforming growth factor ß1 (TGFß1) was used to stimulate fibroblast activation. A decreased expression level of Bcl6 was observed in fibroblasts after stimulation with TGFß1. Then, cells were transfected with adenovirus Bcl6 to overexpress Bcl6. The results showed that Bcl6 overexpression induced decreased proliferation and reduced activation of fibroblasts which were stimulated with TGFß1. It was found that activated smad2 and smad3 were not changed by overexpressing Bcl6, but smad4 was decreased. Furthermore, co-immunoprecipitation results showed that Bcl6 directly bound to smad4, and induced down-regulation of smad4. At last, smad4 activator could counteract the anti-fibroblast effects of Bcl6. In conclusion, Bcl6 may negatively regulate cardiac fibroblast activation and function by directly binding to smad4.

References

[1] MaZG, YuanYP, WuHM, et al.. Cardiac fibrosis: new insights into the pathogenesis. Int J Biol Sci., 2018, 14(12): 1645-1657

[2] FrangogiannisNG. Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities. Mol Aspects Med, 2019, 65: 70-99

[3] LiL, ZhaoQ, KongW. Extracellular matrix remodeling and cardiac fibrosis. Matrix Biol, 2018, 68–69: 490-506

[4] Al HattabD, CzubrytMP. A primer on current progress in cardiac fibrosis. Can J Physiol Pharmacol, 2017, 95(10): 1091-1099

[5] Leeman-NeillRJ, BhagatG. BCL6 as a therapeutic target for lymphoma. Expert Opin Ther Targets, 2018, 22(2): 143-152

[6] CardenasMG, OswaldE, YuW, et al.. The Expanding Role of the BCL6 Oncoprotein as a Cancer Therapeutic Target. Clin Cancer Res, 2017, 23(4): 885-893

[7] WeiZ, GaoW, WuY, et al.. Mutual interaction between BCL6 and miRNAs contributing to the pathogenesis of various cancers. Clin Transl Oncol, 2015, 17(11): 841-846

[8] YoshidaT, FukudaT, HatanoM, et al.. The role of Bcl6 in mature cardiac myocytes. Cardiovasc Res, 1999, 42(3): 670-679

[9] AltieriP, SpallarossaP, BarisioneC, et al.. Inhibition of doxorubicin-induced senescence by PPARdelta activation agonists in cardiac muscle cells: cooperation between PPARdelta and Bcl6. PLoS One, 2012, 7(9): e46126

[10] GuY, LuoM, LiY, et al.. Bcl6 knockdown aggravates hypoxia injury in cardiomyocytes via the P38 pathway. Cell Biol Int, 2019, 43(2): 108-116

[11] BhandaryB, MengQ, JamesJ, et al.. Cardiac Fibrosis in Proteotoxic Cardiac Disease is Dependent Upon Myofibroblast TGF-p¹ Signaling. J Am Heart Assoc, 2018, 7(20): e010013

[12] GohKY, HeL, SongJ, et al.. Mitoquinone ameliorates pressure overload-induced cardiac fibrosis and left ventricular dysfunction in mice. Redox Biol, 2019, 21: 101-100

[13] PattarS F, HassanabadA, FedakPWM. Targeting selected extracellular matrix components to attenuate cardiac fibrosis. Ann Transl Med, 2018, 6(Suppl1): S49

[14] HuS, CaoB, ZhangM, et al.. Epigenetic silencing BCL6B induced colorectal cancer proliferation and metastasis by inhibiting P53 signaling. Am J Cancer Res, 2015, 5(2): 651-662

[15] LiY, ZhangX, YangZ, et al.. miR-339-5p inhibits metastasis of non-small cell lung cancer by regulating the epithelial-to-mesenchymal transition. Oncol Lett, 2018, 15(2): 2508-2514

[16] FelisbinoMB, McKinseyTA. Epigenetics in Cardiac Fibrosis: Emphasis on Inflammation and Fibroblast Activation. JACC Basic Transl Sci, 2018, 3(5): 704-715

[17] WuQQ, NiJ, ZhangN, et al.. Andrographolide Protects against Aortic Banding-Induced Experimental Cardiac Hypertrophy by Inhibiting MAPKs Signaling. Front Pharmacol, 2017, 8: 808

[18] JiangXH, WuQQ, XiaoY, et al.. Evodiamine Prevents Isoproterenol-Induced Cardiac Fibrosis by Regulating Endothelial-to-Mesenchymal Transition. Planta Med, 2017, 83(9): 761-769

[19] WangD, LongJ, DaiF, et al.. BCL6 represses Smad signaling in transforming growth factor-beta resistance. Cancer Res, 2008, 68(3): 783-789